Group One Trading’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-12,900
| Closed | -$44K | – | 5829 |
|
|
2018
Q3 | $44K | Sell |
12,900
-1,900
| -13% | -$6.85K | ﹤0.01% | 4047 |
|
|
2018
Q2 | $56K | Sell |
14,800
-19,400
| -57% | -$94.5K | ﹤0.01% | 3895 |
|
|
2018
Q1 | $140K | Sell |
34,200
-43,300
| -56% | -$202K | ﹤0.01% | 3029 |
|
|
2017
Q4 | $360K | Buy |
77,500
+61,700
| +391% | +$340K | ﹤0.01% | 2519 |
|
|
2017
Q3 | $112K | Sell |
15,800
-63,900
| -80% | -$459K | ﹤0.01% | 3169 |
|
|
2017
Q2 | $576K | Buy |
79,700
+9,400
| +13% | +$58.7K | 0.01% | 1872 |
|
|
2017
Q1 | $433K | Sell |
70,300
-95,100
| -57% | -$521K | 0.01% | 1938 |
|
|
2016
Q4 | $969K | Sell |
165,400
-99,000
| -37% | -$541K | 0.01% | 1335 |
|
|
2016
Q3 | $1.4M | Buy |
264,400
+90,200
| +52% | +$486K | 0.02% | 1054 |
|
|
2016
Q2 | $1.15M | Buy |
174,200
+94,400
| +118% | +$528K | 0.01% | 1169 |
|
|
2016
Q1 | $373K | Sell |
79,800
-84,400
| -51% | -$337K | 0.01% | 1902 |
|
|
2015
Q4 | $829K | Sell |
164,200
-49,900
| -23% | -$237K | 0.01% | 1439 |
|
|
2015
Q3 | $754K | Buy |
214,100
+75,100
| +54% | +$503K | 0.01% | 1470 |
|
|
2015
Q2 | $1.39M | Buy |
139,000
+106,400
| +326% | +$1.14M | 0.02% | 973 |
|
|
2015
Q1 | $415K | Sell |
32,600
-83,300
| -72% | -$1.07M | 0.01% | 1762 |
|
|
2014
Q4 | $1.64M | Sell |
115,900
-110,100
| -49% | -$1.71M | 0.02% | 761 |
|
|
2014
Q3 | $3.11M | Buy |
226,000
+70,500
| +45% | +$1.08M | 0.05% | 472 |
|
|
2014
Q2 | $2.39M | Sell |
155,500
-376,200
| -71% | -$5.33M | 0.04% | 598 |
|
|
2014
Q1 | $9.06M | Buy |
531,700
+219,400
| +70% | +$3.31M | 0.15% | 115 |
|
|
2013
Q4 | $4.04M | Buy |
312,300
+6,100
| +2% | +$72.8K | 0.06% | 325 |
|
|
2013
Q3 | $3.09M | Sell |
306,200
-115,600
| -27% | -$1.03M | 0.06% | 352 |
|
|
2013
Q2 | $3.15M | Buy |
+421,800
| New | +$3.3M | 0.08% | 248 |
|
Group One Trading's KERX Position: Q4 2018 in Review
Group One Trading sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 6,876 shares — an estimated $23K sold.
Group One Trading first reported a position in KERX in Q2 2013 and held it in 21 quarters. The position peaked at $4.35M in Q4 2013. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.
- Group One Trading reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
- Group One Trading sold 6,876 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $23K.
- Group One Trading first reported a position in Keryx Biopharmaceuticals Inc in Q2 2013 and held it in 21 quarters.
- Group One Trading's Keryx Biopharmaceuticals Inc position peaked at $4.35M in Q4 2013.
- 1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.
Based on Group One Trading's 13F filing for Q4 2018, filed 6 Feb 2019.